Syra Health Corp. Class A Common Stock
SYRA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,688 | $1,946 | $1,858 | $2,007 |
| % Growth | -13.3% | 4.8% | -7.4% | – |
| Cost of Goods Sold | $1,133 | $1,193 | $1,269 | $1,551 |
| Gross Profit | $555 | $753 | $589 | $455 |
| % Margin | 32.9% | 38.7% | 31.7% | 22.7% |
| R&D Expenses | $1 | $30 | $37 | -$5 |
| G&A Expenses | $192 | $780 | $1,018 | $955 |
| SG&A Expenses | $252 | $780 | $1,019 | $955 |
| Sales & Mktg Exp. | $0 | $0 | $1 | $0 |
| Other Operating Expenses | $534 | $6 | $7 | $7 |
| Operating Expenses | $787 | $816 | $1,062 | $957 |
| Operating Income | -$232 | -$63 | -$473 | -$502 |
| % Margin | -13.8% | -3.2% | -25.5% | -25% |
| Other Income/Exp. Net | $6 | -$0 | $1 | -$3 |
| Pre-Tax Income | -$226 | -$64 | -$472 | -$504 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$226 | -$64 | -$472 | -$504 |
| % Margin | -13.4% | -3.3% | -25.4% | -25.1% |
| EPS | -0.019 | -0.01 | -0.065 | -0.069 |
| % Growth | -89% | 84.6% | 6.3% | – |
| EPS Diluted | -0.019 | -0.01 | -0.065 | -0.069 |
| Weighted Avg Shares Out | 11,939 | 11,939 | 7,265 | 7,265 |
| Weighted Avg Shares Out Dil | 11,939 | 11,939 | 7,265 | 7,265 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $3 | $4 | $3 |
| Interest Expense | $0 | $4 | $3 | $6 |
| Depreciation & Amortization | $4 | $6 | $7 | $7 |
| EBITDA | -$222 | -$54 | -$462 | -$492 |
| % Margin | -13.1% | -2.8% | -24.9% | -24.5% |